Consolidated Statements of Shareholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Shares balance beginning of period (in shares) at Jan. 02, 2021		221
Balance at beginning of period at Jan. 02, 2021	$ 3,530	$ 2	$ 2,901	$ 661	$ (34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	10		10
Proceeds from employee stock purchase plan	5		5
Vested restricted stock units, net (in shares)		1
Vested restricted stock units, net	0		0
Exercise of stock options (in shares)		0
Exercise of stock options	4		4
Tax withholding payments for net share-settled equity awards	(12)		(12)
Series A convertible preferred stock dividends	(15)			(15)
Unrecognized gain (loss) on interest rate swaps, net of income tax	2				2
Net income	(24)			(24)
Shares balance end of period (in shares) at Apr. 03, 2021		222
Balance at end of period at Apr. 03, 2021	3,500	$ 2	2,908	622	(32)
Shares balance beginning of period (in shares) at Jan. 02, 2021		221
Balance at beginning of period at Jan. 02, 2021	3,530	$ 2	2,901	661	(34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	95
Shares balance end of period (in shares) at Oct. 02, 2021		223
Balance at end of period at Oct. 02, 2021	3,648	$ 2	2,952	723	(29)
Shares balance beginning of period (in shares) at Apr. 03, 2021		222
Balance at beginning of period at Apr. 03, 2021	3,500	$ 2	2,908	622	(32)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	13		13
Proceeds from employee stock purchase plan	5		5
Exercise of stock options	8		8
Tax withholding payments for net share-settled equity awards	(1)		(1)
Series A convertible preferred stock dividends	(9)			(9)
Unrecognized gain (loss) on interest rate swaps, net of income tax	2				2
Net income	55			55
Shares balance end of period (in shares) at Jul. 03, 2021		222
Balance at end of period at Jul. 03, 2021	3,573	$ 2	2,933	668	(30)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	13		13
Proceeds from employee stock purchase plan	6	$ 1	6
Exercise of stock options	1		1
Series A convertible preferred stock dividends	(9)			(9)
Unrecognized gain (loss) on interest rate swaps, net of income tax	1				1
Net income	64			64
Shares balance end of period (in shares) at Oct. 02, 2021		223
Balance at end of period at Oct. 02, 2021	3,648	$ 2	2,952	723	(29)
Shares balance beginning of period (in shares) at Jan. 01, 2022		223
Balance at beginning of period at Jan. 01, 2022	3,735	$ 2	2,970	782	(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	12		12
Proceeds from employee stock purchase plan	5		5
Vested restricted stock units, net (in shares)		1
Vested restricted stock units, net	0		0
Exercise of stock options (in shares)		0
Exercise of stock options	2		2
Tax withholding payments for net share-settled equity awards	(16)		(16)
Series A convertible preferred stock dividends	(9)			(9)
Net income	(7)			(7)
Shares balance end of period (in shares) at Apr. 02, 2022		224
Balance at end of period at Apr. 02, 2022	3,722	$ 2	2,973	766	(19)
Shares balance beginning of period (in shares) at Jan. 01, 2022		223
Balance at beginning of period at Jan. 01, 2022	3,735	$ 2	2,970	782	(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	172
Shares balance end of period (in shares) at Oct. 01, 2022		225
Balance at end of period at Oct. 01, 2022	3,927	$ 2	3,017	927	(19)
Shares balance beginning of period (in shares) at Apr. 02, 2022		224
Balance at beginning of period at Apr. 02, 2022	3,722	$ 2	2,973	766	(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	9		9
Proceeds from employee stock purchase plan	7		7
Exercise of stock options	5		5
Series A convertible preferred stock dividends	(9)			(9)
Net income	70			70
Shares balance end of period (in shares) at Jul. 02, 2022		224
Balance at end of period at Jul. 02, 2022	3,804	$ 2	2,994	827	(19)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	109
Shares balance end of period (in shares) at Oct. 01, 2022		225
Balance at end of period at Oct. 01, 2022	$ 3,927	$ 2	$ 3,017	$ 927	$ (19)